High-throughput structural biology of metabolic enzymes and its impact on human diseases.

The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...

Full description

Bibliographic Details
Main Authors: Yue, W, Oppermann, U
Format: Journal article
Language:English
Published: 2011
_version_ 1797098109179789312
author Yue, W
Oppermann, U
author_facet Yue, W
Oppermann, U
author_sort Yue, W
collection OXFORD
description The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the structures of more than 140 human metabolic enzymes from diverse protein families such as oxidoreductases, hydrolases, oxygenases and fatty acid transferases. A subset of our target proteins are involved in the inherited disorders of carbohydrate, fatty acid, amino acid and vitamin metabolism. This article will provide an overview of the structural data gathered from our high-throughput efforts and the lessons learnt in the structure-function relationship of these enzymes, small molecule development and the molecular basis of disease mutations.
first_indexed 2024-03-07T05:04:57Z
format Journal article
id oxford-uuid:d99a707a-c3df-4656-93db-cbbac149f1ce
institution University of Oxford
language English
last_indexed 2024-03-07T05:04:57Z
publishDate 2011
record_format dspace
spelling oxford-uuid:d99a707a-c3df-4656-93db-cbbac149f1ce2022-03-27T08:57:02ZHigh-throughput structural biology of metabolic enzymes and its impact on human diseases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d99a707a-c3df-4656-93db-cbbac149f1ceEnglishSymplectic Elements at Oxford2011Yue, WOppermann, UThe Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the structures of more than 140 human metabolic enzymes from diverse protein families such as oxidoreductases, hydrolases, oxygenases and fatty acid transferases. A subset of our target proteins are involved in the inherited disorders of carbohydrate, fatty acid, amino acid and vitamin metabolism. This article will provide an overview of the structural data gathered from our high-throughput efforts and the lessons learnt in the structure-function relationship of these enzymes, small molecule development and the molecular basis of disease mutations.
spellingShingle Yue, W
Oppermann, U
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title_full High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title_fullStr High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title_full_unstemmed High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title_short High-throughput structural biology of metabolic enzymes and its impact on human diseases.
title_sort high throughput structural biology of metabolic enzymes and its impact on human diseases
work_keys_str_mv AT yuew highthroughputstructuralbiologyofmetabolicenzymesanditsimpactonhumandiseases
AT oppermannu highthroughputstructuralbiologyofmetabolicenzymesanditsimpactonhumandiseases